Nagi S El Saghir

11PUBLICATIONS
68CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Psychosocial aspects of childbirth and perinatal mental healthCancer geneticsCancer cell biology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Feb 23, 2026
Real-world prevalence of PD-L1 positivity in early-stage/metastatic triple-negative breast cancer: primary results and pathology insights from the global retrospective observational VANESSA study.

Corrado D'Arrigo, Sitki Tuzlali, Romualdo Barroso-Sousa

|Jan 23, 2025
International Medical Graduates, Brain Drain, ASCO, and Global Oncology.

Nagi S El Saghir

|Jul 10, 2024
Tailoring neoadjuvant systemic therapy in breast cancer: "The advent of a personalized approach"-The Breast-Gynecological and Immuno-Oncology International Cancer Conference (BGICC) consensus and recommendations.

Hesham Elghazaly, Hamdy A Azim, Hope S Rugo

|May 21, 2024
Final Results of RIGHT Choice: Ribociclib Plus Endocrine Therapy Versus Combination Chemotherapy in Premenopausal Women With Clinically Aggressive Hormone Receptor-Positive/Human Epidermal Growth Factor Receptor 2-Negative Advanced Breast Cancer.

Yen-Shen Lu, Eznal Izwadi Bin Mohd Mahidin, Hamdy Azim

|Jan 11, 2024
Systemic Treatment of Patients With Metastatic Breast Cancer: ASCO Resource-Stratified Guideline.

Sana Al Sukhun, Sarah Temin, Carlos H Barrios

|May 25, 2023
Improved Survival of Young Patients With Breast Cancer 40 Years and Younger at Diagnosis.

Nagi S El Saghir, Lana E Khalil, Joud El Dick

Pageof 2

Frequent Collaborators

2 joint publications

Yen-Shen Lu

2 joint publications

Seock-Ah Im

2 joint publications

Lana E Khalil

2 joint publications

Hagar Elghazawy